3 assets in Penile Neoplasm

Therapeutic assets addressing Penile Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nivolumab Penile Neoplasm	Instituto do Cancer do Estado de São Paulo	P2	B (57)
Ganciclovir Penile Neoplasm	Gene Surgery LLC	P1	CC (47)
Stimotimagene Copolymerplasmid Penile Neoplasm	Gene Surgery LLC	P1	CC (47)